Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kun He
Observed name:
HE Kun
Institution:
Chongqing Public Health Medical Center
Observed institution:
Chongqing Public Health Medical Center
ORCID:
0000-0002-0587-2313
Observed ORCID:
0000-0002-0587-2313
OpenAlex ID:
A5057375017
Pretreatment drug resistance in people living with HIV: A large retrospective cohort study in Chongqing, China
2022
·
Min Liu
, Xiao‐Qing He
, et al.
·
HIV Medicine
·
23
PDF
Common Adverse Reactions and Management Strategies of First-Line Anti-Tuberculosis Drugs
2026
·
Kun He
, Jing Zhang
, et al.
·
Infection and Drug Resistance
·
11
PDF
Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in initiating ART among HIV-Infected patients in China-risk factors and management
2024
·
Honghong Yang
, Qian Liu
, et al.
·
BMC Infectious Diseases
·
11
PDF
Prevalence of, risk factors for, and target organ damage from metabolic syndrome among people living with HIV on ART : A cross‐sectional analysis in Chongqing, China
2023
·
Min Liu
, Kun He
, et al.
·
HIV Medicine
·
6
PDF
Amphotericin B Colloidal Dispersion is Efficacious and Safe for the Management of Talaromycosis in HIV-Infected Patients: Results of a Retrospective Cohort Study in China
2024
·
Min Liu
, Honghong Yang
, et al.
·
Infection and Drug Resistance
·
5
Correction: Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome in initiating ART among HIV-Infected patients in China-risk factors and management
2024
·
Honghong Yang
, Qian Liu
, et al.
·
BMC Infectious Diseases
·
5
PDF
HIV/AIDS patients with low-level viremia in different states have variable risks of subsequent viral suppression failure: a large retrospective study in Chongqing
2026
·
Yongjia Fu
, Kun He
, et al.
·
Frontiers in Public Health
PDF
Prevalence and transmission of pretreatment drug resistance and acquired drug resistance among people living with HIV-1 in Chongqing, China, 2014–2024
2026
·
Wenwan Gao
, Jungang Li
, et al.
·
Frontiers in Public Health
Albuvirtide plus 3BNC117 provides a promising combination strategy for multidrug-resistant HIV-1 infection: a prospective, open-label, multicenter phase 2 trial
2026
·
Yihong Zhou
, Yuanyuan Qin
, et al.
·
BMC Infectious Diseases
Analysis of the Virological Failure Rates and Influencing Factors of ART Regimens Containing Integrase Inhibitors: A Retrospective Analysis from the Real World in Chongqing
2025
·
Kun He
, Yanming Zeng
, et al.
·
Research Square
PDF
Optimization of an Antiviral Treatment Regimen for Immunological Nonresponders Through HIV-DNA Resistance Testing: A Case Report
2025
·
Kun He
, Xiang Du
, et al.
·
Journal of the International Association of Providers of AIDS Care (JIAPAC)
Consistent efficacy of B/F/TAF in treatment-naïve HIV patients across different baseline HIV-1 RNA levels at week 48
2023
·
Kun He
, Yihong Zhou
, et al.
·
Chinese Medical Journal
Show more works
View as search
Works count:
13
Citation count:
62
H-index:
5
I10-index:
3
Year
Topic
Type